Peer helpers may boost genetic testing in black men with prostate cancer
NCT ID NCT05487846
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study looks at whether having a trained peer navigator—someone who guides patients through the process—helps African American men with advanced prostate cancer better understand and complete genetic testing. Genetic testing is important for treatment decisions, but many patients find it confusing or mistrust the system. The study will compare men who get a peer navigator to those who don't, to see if it improves engagement and reduces decision-making difficulty.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for METASTATIC PROSTATE CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University
RECRUITINGPhiladelphia, Pennsylvania, 19107, United States
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a three-drug cocktail outsmart resistant prostate cancer?
- Precision radiation may tame rising PSA after prostate surgery
- Double-Dose precision: new combo radiation aims to shrink prostate tumors faster
- New hope for advanced bladder cancer? bevacizumab combo tested
- Intermittent fasting tested to ease radiation side effects in cancer patients
- Supercharged immune cells take on Hard-to-Treat prostate cancer